All events occur at the Gaylord National Resort & Convention Center, unless otherwise noted. Schedule is subject to change.

6:00 am – 7:00 am           Postgraduate Courses Breakfast
                                       Room: National Harbor Foyer

Please check in at registration located on the Level 1 foyer for your meeting materials.

7:00 am – 5:00 pm           POSTGRADUATE COURSES

7:00 am – 10:00 am
P1: Outpatient Vascular Centers
Room: National Harbor 2/3

At the end of this session, participants should be able to:

1. Identify the reimbursement system differences governing the delivery of vascular care in inpatient and outpatient systems.
2. Describe the advantages and disadvantages of providing invasive diagnostic and therapeutic endovascular procedures in an outpatient setting.
3. Describe the important legal and regulatory features and requirements necessary to provide a safe environment for outpatient vascular therapy.
4. Explain the capabilities and deficiencies of both fixed and mobile fluoroscopic imaging systems and the environments each are best utilized.
5. Describe the essential administrative functions and staffing needs necessary to provide safe and efficient care for vascular patients in an outpatient setting.

Moderators: David H. Deaton MD, Georgetown University Hospital, Washington, DC, Samuel S. Ahn MD, University Vascular Associates, Los Angeles, CA

7:00 am
Introduction
David H. Deaton MD, Georgetown University Hospital, Washington, DC

Description of Four Outpatient Vascular Centers

7:05 am
California and Texas
Samuel S. Ahn MD, University Vascular Associates, Los Angeles, CA

7:15 am
Tennessee
L. Richard Sprouse II MD, University of Tennessee, Chattanooga, TN

7:25 am
Florida
Russell H. Samson MD, Mote Vascular Foundation and Sarasota Vascular Specialists, Sarasota, FL

7:35 am
Michigan
Krishna M. Jain MD, Advanced Vascular Surgery, Kalamazoo, MI

7:45 am
Panel Discussion

8:15 am
Pros and cons of and how to set up and run CT and MR scanners
Dean Vinson, Family Radiology of Denton, LLC, Carrollton, Texas

8:25 am
Business Administration in Outpatient Vascular Care
Samuel S. Ahn MD, University Vascular Associates, Los Angeles, CA

8:45 am
Legal and Regulatory Aspects of Outpatient Vascular Care
Carol K. Lucas JD, BuchalterNemer, Los Angeles, CA

9:05 am
Reimbursement for Vascular Procedures: Contrasting Inpatient and Outpatient Settings
Sean P. Roddy MD, The Vascular Group PLLC, Albany, NY

Other Issues

9:25 am
What Equipment:  Fixed Vs. Mobile Fluoroscopy
Russell H. Samson MD, Mote Vascular Foundation and Sarasota Vascular Specialists, Sarasota, FL

9:30 am
What Procedures:  Arterial / Venous / Access / Screening
Samuel S. Ahn MD, University Vascular Associates, Los Angeles, CA

9:35 am
Quality Control / Future of Accreditation
David H. Deaton MD, Georgetown University Hospital, Washington, DC

9:40 am
Panel Discussion

P2: Advanced Imaging Techniques (IVUS, fusion, 3D ultrasound)
Room: National Harbor 10/11

At the end of this session, participants should be able to:

1. Describe the basic principles and mechanics of IVUS.
2. Explain the application of IVUS to the treatment of PAD and AAA.
3. Identify the risks and benefits of specific contrast agents.
4. Describe the developments and applications of upcoming vascular imaging techniques such as contrast enhanced US, diffusion weighted MRI, and fusion imaging.

Moderators: Matthew J. Eagleton MD, The Cleveland Clinic, Cleveland, OH
Irwin M. Best MD, Emory University Hospital, Atlanta, GA

7:00 am
IVUS Technology (Mechanical Probes, Phased Array Probes, Virtual Histology)
Sean P. Lyden MD, The Cleveland Clinic Foundation, Cleveland, OH

Routine IVUS is useful for Occlusive Disease Interventions: Debate Pro and Con
7:15 am

Pro:
Vikram S. Kashyap MD, University Hospitals Case Medical Center, Cleveland, OH

7:23 am
Con:
Darren B. Schneider MD, Weill Cornell Medical College, New York, NY

7:31 am
Rebuttal

7:35 am
IVUS for Aortic Disease
Bart E. Muhs MD, Yale University School of Medicine, New Haven, CT

7:45 am
Panel Discussion

7:55 am
Contrast Enhanced Ultrasound and 3D Ultrasound Imaging
Ravi K. Veeraswamy MD, Emory University School of Medicine, Atlanta, GA

8:05 am 
Diffusion Weighted MRI – Technique, Indications, and Application
Irwin M. Best MD, Emory University Hospital, Atlanta, GA

8:15 am
CO2 Angiography
Fred A. Weaver MD, Keck School of Medicine, Los Angeles, CA

8:25 am
Contrast Agents, Allergies, and Renal Issues
Peter R. Nelson MD, University of Florida College of Medicine, Gainesville, FL

8:35 am
Panel Discussion

8:50 am
Fusion Imaging In the OR:  Introduction and Techniques
Zachary M. Arthurs MD, Uniformed Services University of Health Sciences, Bethesda, MD

9:05 am
Managing the Techs  ̶  Training and Applications
Mark A. Farber MD, University of North Carolina Hospitals, Chapel Hill, NC

9:15 am
Upcoming Imaging Platforms:

9:15 am
Siemens
Wei Zhou MD, Stanford University, Stanford, CA

9:20 am
Philips
Heron E. Rodriguez MD, Northwestern University, Chicago, IL

9:25 am
GE
James D. Balshi MD, St. Luke's Hospital, Bethlehem, PA

9:30 am
Panel Discussion  

10:00 am – 10:15 am       Coffee Break
                                        Room: National Harbor Foyer

10:15 am – 1:15 pm         P3: Update on Wound Management in the Vascular Patient
                                        Room: National Harbor 2/3

At the end of this session, participants should be able to: 

1. Classify wounds by type, severity and etiology.
2. Diagnose and correct the underlying arterial and venous pathophysiology to achieve and maintain healing.
3. Explain the role of debridement, dressings, skin substitutes and NPWT for wound bed preparation.

Moderators: Edmond J. Raker MD, Virginia Mason Clinic, Seattle, WA
George Andros MD, Valley Presbyterian Hospital, Van Nuys, CA

10:15 am
Wound Types and Pathophysiology and How to Manipulate the Wound Healing Process
Edmond J. Raker MD, Virginia Mason Clinic, Seattle, WA

10:35 am
Arterial and Venous Ulcers: Similarities and Differences in Their Topical Management
William A. Marston MD, University of North Carolina School of Medicine, Chapel Hill, NC

10:55 am
The Role of Skin Substitutes; Preparing the Wound Bed
Richard C. Baynosa MD, University of Nevada School of Medicine, Las Vegas, NV

11:15 am
The Role of Hyperbaric Oxygen in Wound Management
Thomas E. Serena MD FACS, SerenaGroup, Cambridge, MA

11:35 am
Diagnosing And Treating The Arterial Disease That Causes Ulceration And Gangrene:   How Much Reperfusion Is Enough?
Joseph L. Mills MD, University of Arizona, Tucson, AZ

11:55 am
Diagnosing and Treating the Abnormal Hemodynamics of Venous Ulceration
Seshadri Raju, MD, River Oaks Hospital, Flowood, MS

12:15 pm
Diabetic Foot Ulcers: Debridement, Offloading, And General Management
John S. Steinberg DPM FACFAS, Georgetown University School of Medicine, Washington, DC

12:35 pm
Wound Management Centers Can Be Synergistic To a Vascular Surgical Practice
Damon S. Pierce MD, Virginia Mason Medical Center, Seattle, WA

12:55 pm
Discussion

10:15 am - 1:15 pm          P4: New Emerging Technologies
                                        Room: National Harbor 10/11

At the end of this session, participants should be able to: 

1. Describe the theory behind renal denervation therapy for the treatment of refractory hypertension, along with the current clinical data.
2. Identify the new devices and methods available for treatment of aneurysms of the aortic arch.
3. Identify the various devices available for the treatment of juxtarenal and pararenal abdominal aortic aneurysms.
4. Cite the current data supporting the use of drug eluting balloons for the treatment of SFA and Popliteal artery occlusive disease.
5. Compare the pros and cons of using venous balloon angioplasty to treat patients with multiple sclerosis.
6. List the benefits and disadvantages of new sac filling technology, repositionable grafts, and other new infrarenal AAA advices.
7. Describe the role of transaortic valve replacement and open aortic valve repair in the management of critical aortic stenosis.

Moderators: Christopher J. Kwolek MD, Massachusetts General Hospital, Boston, MA
Edward Y. Woo MD, Hospital of the University of Pennsylvania, Philadelphia, PA

 

10:15 am
Renal Denervation for Treatment of Hypertension – What Is It? How Does It Work? Will This Be Cost Effective And Durable Or Should We Just Stick With Medical Therapy?
Sharif H. Ellozy MD, The Mount Sinai Medical Center, New York, NY

 

10:30 am
Aortic Arch Aneurysms – What Is Currently Available? What New Technologies Are Being Developed To Deal With This Complicated Problem?
Ross Milner MD, University of Chicago Medical Center, Chicago, IL

 

10:45 am
“Off The Shelf” Endografts For Fenestrated And Pararenal Aneurysms – What Technologies Currently Exist And What Are In Development For Treatment Of Complex Aortic Pathology?
Luis A. Sanchez MD, Washington University School of Medicine, St. Louis, MO

 

11:00 am
Drug Eluting Balloons for the Treatment of SFA and Popliteal Disease – What Does the Current Data Suggest and Will This Be a Cost Effective Therapy?
Christopher J. Abularrage MD, The Johns Hopkins Hospital, Baltimore, MD

 

11:15 am
Discussion

 

11:35 am
Break

 

Debate: Balloon venoplasty for the treatment of chronic cerebrospinal insufficiency (CCSVI)

 

11:45 am
Introduction – What Is The Technology?  How Does It Work? What Is The Availability Inside And Outside The United States?
Christopher J. Kwolek MD, Massachusetts General Hospital, Boston, MA

 

11:48 am
Pro – Balloon Venoplasty Is a Promising Technology for the Treatment of Multiple Sclerosis
Manish Mehta MD, The Institute for Vascular Health & Disease, Albany, NY

 

11:58 am
Con – This Is Nothing More Than Placebo Effect And Needs To Be Proven In Prospective Randomized Trials Before It Is Accepted
Daniel G. Clair MD, The Cleveland Clinic, Cleveland, OH

 

12:08 pm
Discussion

 

Debate: New Endograft Technology for the Treatment of Infrarenal AAA

 

12:15 pm
Introduction – What is the new Technology?  How Does it Work? What is the Availability inside and outside the United States?
Edward Y. Woo MD, Hospital of the University of Pennsylvania, Philadelphia, PA

 

12:18 pm
Pro – New Technology for Endografts Will Improve the Current Outcomes for Treating Infrarenal AAA – (Lower Profile Grafts, Repositionable Grafts, Sac Obliteration Technology, Multilayer Flow Limiting Stents)
Joseph V. Lombardi MD, Cooper University Hospital, Camden, NJ

 

12:28 pm
Con – Current EVAR Technology Is More Than Sufficient and These New Grafts Are Just a Waste of Time and Money
Mark F. Conrad MD, Massachusetts General Hospital, Boston, MA

 

12:38 pm
Discussion

 

Debate: Transaortic Valve Replacement for the Management of Critical Aortic Stenosis

 

12:45 pm
Introduction – What is the new Technology?  How Does it Work? What is the Availability inside and outside the United States?
Christopher J. Kwolek MD, Massachusetts General Hospital, Boston, MA

 

12:48 pm
Pro – Transaortic Valve Replacement Will Be the Main Therapy for Treating Aortic Valvular Disease
Wilson Y. Szeto MD, Hospital of the University of Pennsylvania, Philadelphia, PA

 

12:58 pm
Con – Transaortic Valve Replacement Will Not Replace Open Aortic Valve Replacement, It Is Too Expansive Expensive and Too High Risk
Hazim J. Safi MD, University of Texas Medical School, Houston, TX

 

1:08 pm
Discussion

At the end of this session, participants should be able to: 

1. List the different treatment algorithms for acute and chronic deep venous thrombosis and anticoagulation options and recommendations.
2. Describe current imaging options and treatment modalities for DVT and pulmonary embolic disease as well as the role of ablation therapy in the setting of a DVT.
3. Describe the use of IVC filters between the USA and Canada.
4. Discuss the management of post-thrombotic venous ulcerations.

Moderators: Ruth L. Bush MD, Scott and White Memorial Hospital, Temple, TX
Robert B. McLafferty MD, Southern Illinois University School of Medicine, Springfield, IL
 
Management of Acute DVT

 

2:00 pm
Update On New ACCP Guidelines for Anticoagulation Treatment of Acute DVT
Peter K. Henke MD, University of Michigan, Ann Arbor, MI

 

2:15 pm
The Natural History of Upper Extremity Acute DVT
John E. Rectenwald MD, University of Michigan, Ann Arbor, MI

 

2:30 pm
Novel Endovascular Approaches to the Treatment of Acute DVT of the Lower Extremity
Rabih A. Chaer MD, University of Pittsburgh, Pittsburgh, PA

 

2:45 pm
Defining the Role and Techniques for Endovascular Treatment of Pulmonary Embolism
Panagiotis Kougias MD, Baylor College of Medicine, Houston, TX

 

3:00 pm
Contrasting the Role of Prophylactic Filter Use between the United States and Canada
Marc A. Passman MD, University of Alabama at Birmingham, Birmingham, AL

 

3:15 pm
Practice Development for Vascular Surgeons in the Management of Acute DVT
Colleen J. Moore MD, Southern Illinois University School of Medicine, Springfield, IL

 

3:30 pm
Break

 

Management of Chronic DVT

 

3:45 pm
Venous Stenting: Current Status and New Developments
Anil P. Hingorani MD, Lutheran Medical Center, Brooklyn, NY

 

4:00 pm
Endovascular Techniques and Tips on Recanlization of Iliac and IVC Occlusions
Antonios P. Gasparis MD, Stony Brook Hospital, Stony Brook, NY

 

4:15 pm
Defining the Role of Venous Ablation in Patients with a History of Ipsilateral DVT
Lowell S. Kabnick MD, New York University Medical Center, New York, NY

 

4:30 pm
Current and New Imaging Modalities to Identify Venous Obstruction
Cynthia K. Shortell MD, Duke University Medical Center, Durham, NC

 

4:45 pm
Modern Ulcer Treatment in Patients with Post-Thrombotic Syndrome
William A. Marston MD, University of North Carolina School of Medicine, Chapel Hill, NC

At the end of this session, participants should be able to: 

1. Review instructions for use (IFU) and outcomes related to IFU.
2. Compare and contrast options for preservation of aortic branch patency.
3. Describe technical aspects of branch vessel preservation with endovascular repair (EVR).
4. Identify current and future treatment options in the arena of complex EVR.  

Moderators: Jon S. Matsumura MD, University of Wisconsin School of Medicine and Public Health, Madison, WI, Andres Schanzer MD, University of Massachusetts Medical School, Worcester, MA

2:00 pm
Instructions for Use (IFU)  ̶  What They Mean, How They are Derived, and EVAR Outcomes When They are Ignored
Andres Schanzer, MD, University of Massachusetts Medical School, Worcester, MA

 

Debate: Internal Iliac Preservation in the Setting of Common Iliac Aneurysms

 

2:15 pm
Snorkle/Sandwich Technique
David J. Minion MD, University of Kentucky College of Medicine, Lexington, KY

 

2:25 pm
Iliac Branch Devices
Gustavo Oderich MD, Mayo Clinic, Rochester, MN

 

2:35 pm
Unilateral Hypogastric Artery Embolization Is Benign – No Need for These Complicated Techniques
Girma Tefera MD, University of Wisconsin School of Medicine and Public Health, Madison, WI

 

2:45 pm
Discussion

 

Debate: Short Neck AAA

 

2:55 pm
Snorkle Technique
Jason T. Lee MD, Stanford University Medical Center, Stanford, CA

 

3:05 pm
Homemade Fenestrated Grafts
Benjamin W. Starnes MD, University of Washington, Seattle, WA

 

3:15 pm
Open Repair with Suprarenal Clamp Placement is the Best Way
Mark F. Conrad MD, Massachusetts General Hospital, Boston, MA

 

3:25 pm
Discussion

 

3:35 pm
Break

 

Debate: Thoracic Aneurysms Extending Proximal to the Left Subclavian

 

3:45 pm
Chimney Techniques
Jon S. Matsumura MD, University of Wisconsin School of Medicine and Public Health, Madison, WI

 

3:55 pm
Arch Debranching/Extraanatomic Bypass
Mark A. Farber MD, University of North Carolina Hospitals, Chapel Hill, NC

 

4:05 pm
Fenestrated
Stephan Haulon MD, Hospital Cardiologique, Lille, France

 

4:15 pm
In-Situ Branched Stentgrafts
Takao Ohki MD, The Jikei University School of Medicine, Minato, Tokyo

 

4:25 pm
Discussion

 

4:35 pm
Commercial Options on the US Horizon for Patients Who Don't Meet IFU – Custom and Off-the-shelf Solutions
Stephan Haulon MD, Hospital Cardiologique, Lille, France

 

4:50 pm
Discussion

At the end of this session, the participant will be able to:

1. Discuss recent developments with respect to diagnostic imaging and percutaneous therapies for carotid, mesenteric, renal and lower extremity vasculature.
2. Describe expected outcomes following open and endovascular techniques used to treat abdominal aortic aneurysms, lower extremity revascularization, and combat related vascular injuries in a contemporary setting.
3. Apply up-to-date results in day-to-day practice to maximize success with contemporary open and endovascular techniques across various vascular territories.
4. Discuss recent developments within the field of hemodialysis access creation as well as potential complications which may arise and influence patient outcomes.

Moderators: Matthew A. Corriere MD MS, Emory University School of Medicine, Atlanta, GA, Robert J. Feezor MD, University of Florida Vascular Surgery, Gainesville, FL

9:30 am
PVSS1. Long-term Functional Outcomes of Brachio-Basilic Arterio-Venous Fistulas
Casey Yossa, Dean Healy, Satish Muluk
Cardiovascular & Thoracic Surgery, West Penn Allegheny Health System, Pittsburgh, PA.

9:45 am
NORMAN M. RICH AWARD
PVSS2. Microvascular Porcine Model for the Optimization of Composite Tissue Autotransplantation
Cpt. Carole Villamaria, Col. Todd Rasmussen, Jerry Spencer, Lt. Col. Michael Davis
U.S. Army Institute of Surgical Research, Ft. Sam Houston, TX.

​​10:00 am
PVSS3. Should Endovenous Ablation of Small Diameter Great Saphenous Veins be Performed on Patients with Symptomatic Varicose Veins?
Steven Perrins, Andrew Cha, Dahlia Plummer, Richard Hsu, Alan M. Dietzek
Surgery, Danbury Hospital, Danbury, CT.

9:45 am
PVSS4. Implementation of the Screen for Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act: A Five-year Follow-up
Kevin C. Chun BS, Kai Y. Teng BS, Elyse N. Van Spyk BS, John G. Carson MD, Eugene S. Lee MD PhD
University of California, Davis and Sacramento VA Medical Center; Sacramento, CA.

10:30 am
PVSS5. Is Depression a Risk Factor for Peripheral Arterial Disease? Insights from the Heart and Soul Study
Marlene Grenon, Hade Hiramoto, Eric Vittinghoff, Mary Whooley, Beth Cohen
UCSF, San Francisco, CA.

10:45 am
PVSS6. In Vivo Assessment of Endothelial Function in Human Lower Extremity Arteries
Vikram S. Kashyap1, Ryan O. Lakin¹, Lindsay Feiten², Paul Bishop², Timur P. Sarac^2
1University Hospitals Case Medical Center, Cleveland, OH; ²The Cleveland Clinic, Cleveland, OH.

11:00 am
PVSS7. Primary Angiosarcoma of the Aorta and Great Vessels
Javairiah Fatima MD, Audra A. Duncan MD, Gustavo S. Oderich MD, Peter Gloviczki MD, Manju Kalra MD, Michael McKusick MD, Thomas C. Bower MD
Mayo Clinic, Rochester, MN.

11:15 am
PVSS8. Ulcer Healing and Prevention of Limb Loss Following Endovascular Tibial Artery Interventions in Patients Presenting with Tissue Loss
Javier E. Anaya-Ayala, Mitul S. Patel, Matthew K. Adams, Christopher J. Smolock, Joseph J. Naoum, Jean Bismuth, Eric K. Peden, Alan Lumsden, Mark G. Davies
Cardiovascular Surgery, Methodist DeBakey Heart & Vascular Center, Houston, TX.

11:30 am
PVSS9. Do Closure Devices Prevent Surgical Complications?
Jason Q. Alexander, Kate Zimmerman, Andrew Cragg, Peter Alden, John Graber, Adnan Rizvi, Alex Tretinyak, Timothy Sullivan
Vascular and Endovascular Surgery, Minneapolis Heart Institute, Minneapolis, MN.

11:45 am
PVSS10. Temporary Distal Vessel Occlusion Using Reversible Thermo-sensitive Polymer in Infra-popliteal Bypasses for Severe Leg Ischemia
Hany Zayed, Jennifer Fitzpatrick, Anwar Ahmad, Bijan Modarai, Hisham Rashid
Vascular Surgery, Kings Health Partners, London, United Kingdom.

12:00 pm
PVSS Award Reports
Room: Maryland D

12:30
PVSS Lunch (on own)

1:30 pm – 5:00 pm           V2: Peripheral Vascular Surgery Society Paper Session II
                                        Room: Maryland D

At the end of this session, the participant will be able to:

1. Examine the outcomes of thoracic surgical and endovascular interventions, as well as the impact of patient selection and emerging technology on these procedures.
2. Discuss recent studies describing national epidemiologic and analytic details surrounding the outcomes of carotid endarterectomy.
3. Explain the impact of readmissions on practice patterns in vascular surgical care.
4. Explain the effectiveness of different strategies for dealing with complications, such as arterial injury, infection, and stroke.

Moderators: Jonathan L. Eliason MD, University of Michigan, Ann Arbor, MI
Ravi K. Veeraswamy MD, Emory University School of Medicine, Atlanta, GA

1:30 pm
PVSS11. Outcomes of Ischemic Colitis After Hybrid Endovascular Repair of Complex Aortic Aneurysms in the North American Complex Abdominal Aortic Debranching (NACAAD) Registry
Carlos H. Timaran¹, Gustavo S. Oderich², Mark A. Farber³, William Quinones-Baldrich⁴, Peter Gloviczki², Guillermo Escobar⁵, Roy K. Greenberg⁶, James Black⁷, Sharif Ellozy⁸, Edward Woo⁹, Michael Singh¹⁰, Mark Fillinger¹¹, Jason Lee¹², Hasan H. Dosluoglu^13
1University of Texas Southwestern Medical Center, Dallas, TX; ²Mayo Clinic, Rochester, MN; ³University of North Carolina, Chapel Hill, NC; ⁴University of California, Los Angeles, CA; ⁵University of Michigan, Ann Arbor, MI; ⁶The Cleveland Clinic, Cleveland, OH; ⁷Johns Hopkins Medical Center, Baltimore, MD; ⁸Mount Sinai School of Medicine, New York, NY; ⁹University of Pennsylvania Medical Center, Philadelphia, PA; ¹⁰University of Rochester Medical Center, Rochester, NY; ¹¹Dartmouth-Hitchcock Medical Center, Lebanon, NH; ¹²Stanford University Medical Center, Stanford, CA; ¹³State University of New York, Buffalo, NY.

1:45 pm
PVSS12. Early and Late Outcomes After Open Thoracic and Thoracoabdominal Aortic Aneurysm Repair in Young Patients
Nanette R. Reed, Manju Kalra, Gustavo Oderich, Audra A. Duncan, Thomas C. Bower, Peter Gloviczki
Vascular Surgery, Mayo Clinic Rochester, Rochester, MN.

2:00 pm
PVSS13. Anatomic Characteristics of Aortic Transection: Centerline Analysis to Facilitate Emergent Repair
Ravi R. Rajani, Laura S. Johnson, Brian L. Brewer, Luke P. Brewster, Matthew A. Corriere, Yazan Duwayri, James G. Reeves, Joseph J. Ricotta, Ravi K. Veeraswamy, Thomas F. Dodson
Department of Vascular Surgery, Emory University, Atlanta, GA.

2:15 pm
PVSS14. Gender Differences in Aortic Aneurysm Presentation, Repair and Mortality in the VSGNE
Ruby C. Lo1, Rodney P. Bensley¹, Allen D. Hamdan1, Mark Wyers¹, Elliot Chaikof¹, Julie E. Adams², Marc L. Schermerhorn^1
1Vascular Surgery, BIDMC, Boston, MA; ²University of Vermont College of Medicine, Burlington, VT.

2:30pm
PVSS15. Outcomes Following TEVAR for Acute & Chronic Type B Aortic Dissection
James Sampson MD, Marjan Mujib MD MPH, Mark A Patterson MD, Marc A Passman MD, Thomas C. Matthews, MD William D. Jordan MD
University of Alabama at Birmingham, Birmingham, AL.

2:45 pm
PVSS16. Perioperative Use of Dextran is Associated with Cardiac Complications After Carotid Endarterectomy
Alik Farber¹, Tze-Woei Tan¹, Jeffrey Kalish¹, Naomi M. Hamburg¹, Robert Eberhardt¹, Gheorghe Doros¹, Denis V. Rybin¹, Philip P. Goodney², Jack L. Cronenwett², For the Vascular Surgery Group of New England
¹Boston Medical Center/Boston University School of Medicine and Public Health, Boston, MA; ²Dartmouth-Hitchcock Medical Center, Lebanon, NH.

3:00 pm
PVSS17. The impact of Centers for Medicaid & Medicare Services (CMS) High-risk (HR) Criteria on Outcome After Carotid Endarterectomy (CEA) and Carotid Artery Stenting (CAS) in the SVS Vascular Registry™ (VR)
Marc L. Schermerhorn1, Philip P. Goodney2, Ellen D. Dillavou3, Jeffrey Jim4, Christopher T. Kenwood5, Flora S. Siami5
1Beth Israel Deaconess Medical Center, Boston, MA; 2Dartmouth-Hitchcock Medical Center, Lebanon, NH; 3University of Pittsburgh Medical Center, Pittsburgh, PA; 4Washington University, St. Louis, MO; 5New England Research Institutes, Inc., Watertown, MA.

3:15 pm
PVSS18. Long-term Clinical and Anatomic Outcomes Following Carotid Endarterectomy
Jeanwan Kang, Virendra I. Patel, Shankha Mukhopadhyay, Ashu Garg, Matthew R. Cambria, Mark F. Conrad, Glenn M. LaMuraglia, Richard P. Cambria
Massachusetts General Hospital, Boston, MA.

3:30 pm
PVSS19. Accuracy of Administrative vs. Clinical Data to Evaluate Carotid Endarterectomy and Carotid Stenting
Rodney P. Bensley, Rob Hurks, Ruby C. Lo, Jeremy D. Darling, Elliot L. Chaikof, Allen D. Hamdan, Mark C. Wyers, Marc L. Schermerhorn
Surgery, Beth Israel Deaconess Medical Center, Boston, MA.

3:45 pm
PVSS20. Evaluating Effectiveness of Antibiotic Polymethylmethacrylate Beads in Treating Early and Late Vascular Graft Infections
Mun Jye Poi MD, George Pisimisis MD, Neal Barshes MD MPH, Peter H. Lin MD, Panagiotis Kougias MD, Carlos F. Bechara MD
Baylor College of Medicine; Houston, TX.

4:00 pm
PVSS21. Patient-based Outcomes Following Wartime Extremity Vascular Injury: An Interim Analysis of the GWOT Vascular Injury Initiative (GWOT-VII)
Daniel J. Scott MD, Adam Stannard MRCS, Zachary M. Arthurs MD, Diane L. Lynd RN, Howard M. Monroe PhD, April C. Ames-Chase RN, William D. Clouse MD, Todd E. Rasmussen MD
San Antonio Military Medical Center, Ft. Sam Houston, TX.

4:15 pm
PVSS22. Racial Disparities and Site of Care in Readmissions After Major Vascular Surgery
Micah Girotti¹, Jonathan L. Eliason², Justin B. Dimick¹, Peter K. Henke^2
1University of Michigan, Department of Surgery, Center for Healthcare Outcomes and Policy, Ann Arbor, MI; ²University of Michigan, Department of Surgery, Section of Vascular Surgery, Ann Arbor, MI.

4:30 pm
PVSS23. Simulation-based Training to Teach Open AAA Repair to Surgical Residents Requires Dedicated Faculty Instruction
William P. Robinson¹, Donald T. Baril¹, Odette Taha¹, Andres Schanzer¹, Anne C. Larkin¹, Jean Bismuth³, Erica L. Mitchell², Louis M. Messina^1
1University of Massachusetts Medical School, UMass Memorial Medical Center, Worcester, MA; ²Oregon Health & Science University, Portland, OR; ³Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, TX.

4:45 pm
PVSS24. Surgical Intervention for Radial Artery Catheter-associated Ischemic Complications
Phong T. Dargon, Timothy K. Liem, Margaret C. Gorman, Amir F. Azarbal, Erica L. Mitchell, Gregory J. Landry, Gregory L. Moneta
Oregon Health & Science University, Portland, OR.

C1: Compensation Methods and Strategies for Improving Revenue in Your Practice
Room: Potomac D

 

At the end of this session, participants should be able to: 

1. Discuss compensation methods that can be used in physician practices through various methods of evaluation and assessment.
2. Identify strategies to utilizing a physician extender to increase productivity, maximize use of a physician's time and improve revenue streams.
3. Determine ways to maximize revenue from the vascular lab through coding reimbursement and introduction of new procedures in an office setting.
4. Discuss how to advantageously utilize a prosthetics department through an office based approach.

Moderators: Dennis R. Gable MD, Baylor Vascular Hospital, Dallas, TX
Tej M. Singh MD, Palo Alto Medical Group, Mountain View, CA

 

5:00 pm
Compensation Methods for Physician Employment Contracts
Bhagwan Satiani MD MBA, Ohio State University, Columbus, OH

 

5:15 pm
Use of Physician Extenders to Your Advantage
James D. Balshi MD FACS, The Vascular Center, Bethlehem PA

 

5:30 pm
Optimizing Coding and Reimbursement for Your Practice
Matthew J. Sideman MD, The University of Texas Health Science Center at San Antonio, San Antonio, TX

 

5:45 pm
Advantages to Use of a Prosthetics Lab in Current Practice
William H. Edwards, Jr. MD, The Surgical Clinic, PLLC, Nashville, TN

 

6:00 pm
Panel Discussion

 

C2: International Symposium: A Dialogue of What is New in Vascular Surgery Across the World
Room: Maryland A

 

At the end of this session, participants should be able to:

1. Discuss the practice issues faced by vascular surgeons across the world.
2. Report on specific vascular disorders that present challenges to treatment in countries outside North America.
3. Explain the relationships between vascular surgeons and other providers that treat patients with vascular disease across the globe.

Moderators: Enrico Ascher MD, Lutheran Medical Center, Brooklyn, NY
Alik Farber MD, Boston Medical Center, Boston, MA

 

5:00 pm
Introduction

 

5:05 pm
Russia
The Surgical Management of Takayasu’s Disease
Anatoly Pokrovsky, A.V. Vishnevsky Institute of Surgery, Moscow, Russia

 

5:15 pm
Columbia
Current Management of Carotid Body Tumors: A Frequent Vascular Condition in High Altitudes
Alberto Munoz MD, Hospital Universitario Fundacion Santafe, Bogota, Colombia

 

5:25 pm
Hungary
Treatment Options for Treatment of Complex Thoracic Aortic Aneurysms
Csaba Dzsinich MD PhD, National Institute of Health of Hungary, Budapest, Hungary

 

5:35 pm
India
Current Management of Infrapopliteal PAD in India
Kumud M. Rai MD, Max Heart & Vascular Institute, New Delhi, India

 

5:45 pm
Brazil
The Sandwich Technique to Maintain Hypogastric Flow During Endovascular Repair of AOA
Armando Lobato MD, San Paulo Vascular and Endovascular Surgery Institute,
San Paulo, Brazil

 

5:55 pm
Panel Discussion

 

C3: Managing Your Practice and Your Life
Room: Maryland C

 

At the end of this session, participants should be able to: 

1. Identify strategies for branding vascular practices.
2. Evaluate social medial opportunities.
3. Develop methods for achieving work/life balance.
4. Describe ways to successfully work with competitors and industry.
5. Explain how to handle financial stressors associated with practice start-up costs.

Moderators: Christopher D. Scibelli MD, Naval Medical Center Portsmouth, Suffolk, VA
Ravi K. Veeraswamy MD, Emory University School of Medicine, Atlanta, GA

 

5:00 pm
Branding Your Practice
Russell H. Samson MD, Mote Vascular Foundation and Sarasota Vascular Specialists, Sarasota, FL

 

5:10 pm
Is Social Media Right for Your Practice?
Bart E. Muhs MD, Yale University School of Medicine, New Haven, CT

 

5:20 pm
Finding Competitive Synergy
Gilbert R. Upchurch, Jr. MD, University of Virginia Medical Center, Charlottesville, VA

 

5:30 pm
Managing Industry Relations
Frank J. Veith MD, The Cleveland Clinic, Cleveland, OH

 

5:40 pm
Staying Sane: The Balance Between Work and Life
Jason T. Lee MD, Stanford University Medical Center, Stanford, CA

 

5:50 pm
Financial Stressors after Graduation
Mark F. Conrad MD, Massachusetts General Hospital, Boston, MA

 

6:00 pm
Panel Discussion

 

C4: The Importance of Mentorship in Professional Development
Room: Maryland 1-3

 

At the end of this session, participants should be able to: 

1. Give insight into effective mentoring relationships and fostering professionalism.
2. Provide guidelines for developing and promoting mentorship programs for students, residents, and young clinical and research faculty.
3. Provide a broad overview of the issues that arise related to mentoring groups with respect to differing generational needs.
4. Provide multiple perspectives on role modeling and guiding others to be successful in their careers.

Moderators: Anil P. Hingorani MD, Lutheran Medical Center, Brooklyn, NY
Erica L. Mitchell MD, Oregon Health & Science University, Portland, OR
Eva M. Rzucidlo MD, Dartmouth-Hitchcock Medical Center, Lebanon, NH

5:00 pm
Importance of Mentoring in Academia
Julie Ann Freischlag MD, Johns Hopkins University School of Medicine, Baltimore MD

5:10 pm
Importance of Mentoring in Private Practice
Samuel R. Money MD, FACS, Mayo Clinic, Phoenix, AZ

 

5:20 pm
Importance of Mentoring to Achieve Success in Research
Frank W. LoGerfo MD, Beth Israel Deaconess Medical Center, Boston, MA

 

5:30 pm
Importance of Mentoring to Achieve Success in Publications
Anton N. Sidawy MD MPH, George Washington University Medical Center, Washington, DC

 

5:40 pm
How Does Diversity Affect Our Ability to Mentor
Frederick P. Beavers MD, Washington Hospital Center, Washington, DC

 

5:50 pm
Engaging the Next Generation without Alienating the Loyalty Generation
Sarah Sladek, XYZ University, Maple Grove, MN

 

6:10 pm
Panel Discussion

 

C5: Regional Quality Groups in the SVS Patient Safety Organization
Room: National Harbor 4/5

 

At the end of this session, participants should be able to: 

1. Organize a regional quality improvement effort within the SVS Vascular Quality Initiative.
2. Describe how to use PSO data for quality improvement and how to conduct research with de-identified data, including methods for data entry, incorporating EMR systems, and linking with claims data.

Moderators: Jens Eldrup - Jorgensen MD, The Maine Surgical Group, Portland, ME
John (Jeb) W. Hallett MD, Roper St. Francis Heart & Vascular Services, Charleston, SC

 

5:00 pm
Current Status of SVS PSO
John (Jeb) W. Hallett MD, Roper St. Francis Heart & Vascular Services, Charleston, SC

 

5:10 pm
How to Organize a Regional Quality Group
Karen Woo MD, University of Southern California, Los Angeles, CA

 

5:20 pm
Using PSO Data for Quality Improvement
Jens Eldrup-Jorgensen MD, The Maine Surgical Group, Portland, ME

 

5:30 pm
Research Using Non-identifiable Data
Andres Schanzer MD, University of Massachusetts Medical School, Worcester, MA

 

5:40 pm
EMR and Claims Data Linkage
Philip P. Goodney MD, Dartmouth-Hitchcock Clinic, Lebanon, NH

 

5:50 pm
Panel Discussion
Adam W. Beck MD, University of Florida College of Medicine, Gainesville, FL
Mark G. Davies MD PhD, Methodist DeBakey Heart and Vascular Center, Houston, TX
Larry W. Kraiss MD, University of Utah Medical Center, Salk Lake City, UT
Gilbert R. Upchurch, Jr. MD, University of Virginia Medical Center, Charlottesville, VA
Fred A. Weaver MD, Keck School of Medicine, Los Angeles, CA

5:30 pm – 9:30 pm           PVSS Banquet
                                        Room: Potomac 1-3

6:30 pm – 8:00 pm           General Surgery Resident/Medical Student Scholarship Program – Welcome
                                        Reception
                                        Room: Lower Atrium (Main Hotel)
                                        

Updated May 2012